Novel 7‐secretase inhibitors uncover a common nucleotide‐binding site in JAK3, SIRT2, and PS1

No abstract is available for this paper.

• Publication year

  2010

• Venue

  The FASEB Journal

• Publication date

  2010-07-01

• Fields of study

  Biology, Medicine, Chemistry

• Identifiers
  DOI 10.1096/fj.09-148031PMID 20237298
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Intramembrane proteolysis.

  2009cited by this paper
• Inhibition of gamma-secretase activity by helical beta-peptide foldamers.

  2009cited by this paper
• Alzheimer's disease: from pathology to therapeutic approaches.

  2009cited by this paper
• The regulation of SIRT2 function by cyclin-dependent kinases affects cell motility

  2008cited by this paper
• Drug Target Identification Using Side-Effect Similarity

  2008cited by this paper
• Structure-activity studies on splitomicin derivatives as sirtuin inhibitors and computational prediction of binding mode.

  2008cited by this paper
• Inhibitory and structural studies of novel coenzyme‐substrate analogs of human histidine decarboxylase

  2008cited by this paper
• Substrate-targeting γ-secretase modulators

  2008cited by this paper
• Selective Amyloid-\ ( \ beta \ ) Lowering Agents

  2008cited by this paper
• Selective amyloid-β lowering agents

  2008cited by this paper
• γ-Secretase: a multifaceted regulator of angiogenesis

  2008cited by this paper
• Nicotinamide Restores Cognition in Alzheimer's Disease Transgenic Mice via a Mechanism Involving Sirtuin Inhibition and Selective Reduction of Thr231-Phosphotau

  2008cited by this paper
• Biological and Potential Therapeutic Roles of Sirtuin Deacetylases

  2008cited by this paper
• Inhibition and modulation of γ-secretase for Alzheimer’s disease

  2008cited by this paper
• O4‐03–05: A molecular investigation of different domains in the gamma‐secretase complex for their substrate interaction

  2008cited by this paper
• Proteomic Profiling of γ-Secretase Substrates and Mapping of Substrate Requirements

  2008cited by this paper
• Structural studies of the transmembrane C-terminal domain of the amyloid precursor protein (APP): does APP function as a cholesterol sensor?

  2008influential reference
• Differential production of superoxide by neuronal mitochondria

  2008cited by this paper
• P2‐338: Substrate‐targeting gamma‐secretase modulators

  2008cited by this paper
• Structural and Functional Determinants of γ-Secretase, an Intramembrane Protease Implicated in Alzheimer’s Disease

  2007cited by this paper
• Tetrahydroquinoline sulfonamides as gamma-secretase inhibitors.

  2007cited by this paper
• Sirtuin 2 Inhibitors Rescue α-Synuclein-Mediated Toxicity in Models of Parkinson's Disease

  2007cited by this paper
• A small-molecule therapeutic lead for Huntington's disease: Preclinical pharmacology and efficacy of C2-8 in the R6/2 transgenic mouse

  2007cited by this paper
• Tetrahydroquinoline sulfonamides as γ-secretase inhibitors

  2007cited by this paper
• 2,6-Disubstituted N-arylsulfonyl piperidines as gamma-secretase inhibitors.

  2007cited by this paper
• 2,6-Disubstituted N-arylsulfonyl piperidines as γ-secretase inhibitors

  2007cited by this paper
• Rapid purification of active γ‐secretase, an intramembrane protease implicated in Alzheimer’s disease

  2007cited by this paper
• SIRT1 activation confers neuroprotection in experimental optic neuritis.

  2007cited by this paper
• Sirtuin 2 inhibitors rescue alpha-synuclein-mediated toxicity in models of Parkinson's disease.

  2007cited by this paper
• Structure of the catalytic pore of gamma-secretase probed by the accessibility of substituted cysteines.

  2006influential reference
• Resveratrol improves health and survival of mice on a high-calorie diet

  2006influential reference
• Effects of a gamma-secretase inhibitor in a randomized study of patients with Alzheimer disease.

  2006cited by this paper
• Adenosine mimetics as inhibitors of NAD+-dependent histone deacetylases, from kinase to sirtuin inhibition.

  2006influential reference
• The GxGD Motif of Presenilin Contributes to Catalytic Function and Substrate Identification of (cid:1) -Secretase

  2006cited by this paper
• Identifying off-target effects and hidden phenotypes of drugs in human cells

  2006cited by this paper
• Contribution of Presenilin Transmembrane Domains 6 and 7 to a Water-containing Cavity in the γ-Secretase Complex*

  2006cited by this paper
• Effects of a γ-secretase inhibitor in a randomized study of patients with Alzheimer disease

  2006cited by this paper
• Faculty Opinions recommendation of Contribution of presenilin transmembrane domains 6 and 7 to a water-containing cavity in the gamma-secretase complex.

  2006cited by this paper
• The GxGD Motif of Presenilin Contributes to Catalytic Function and Substrate Identification of γ-Secretase

  2006cited by this paper
• The GxGD motif of presenilin contributes to catalytic function and substrate identification of gamma-secretase.

  2006cited by this paper
• Crystal structure of the Jak3 kinase domain in complex with a staurosporine analog.

  2005cited by this paper
• γ-Secretase Substrate Selectivity Can Be Modulated Directly via Interaction with a Nucleotide-binding Site*

  2005influential reference
• Mechanism of sirtuin inhibition by nicotinamide: altering the NAD(+) cosubstrate specificity of a Sir2 enzyme.

  2005influential reference
• A high-throughput screen to identify inhibitors of amyloid beta-protein precursor processing.

  2005cited by this paper
• A High-Throughput Screen to Identify Inhibitors of Amyloid β-Protein Precursor Processing

  2005cited by this paper
• Progressive and selective striatal degeneration in primary neuronal cultures using lentiviral vector coding for a mutant huntingtin fragment.

  2005cited by this paper
• Intramembrane Proteolysis: Theme and Variations

  2004cited by this paper
• Tumor necrosis factor-alpha, interleukin-1beta, and interferon-gamma stimulate gamma-secretase-mediated cleavage of amyloid precursor protein through a JNK-dependent MAPK pathway.

  2004cited by this paper
• Uncoupled and surviving: individual mice with high metabolism have greater mitochondrial uncoupling and live longer

  2004cited by this paper
• Diversity in nucleotide binding site-leucine-rich repeat genes in cereals.

  2002cited by this paper
• In vitro metabolism of tegaserod in human liver and intestine: assessment of drug interactions.

  2001cited by this paper
• Identification of a Class of Small Molecule Inhibitors of the Sirtuin Family of NAD-dependent Deacetylases by Phenotypic Screening*

  2001cited by this paper
• A subset of NSAIDs lower amyloidogenic Aβ42 independently of cyclooxygenase activity

  2001cited by this paper
• Structure of the histone deacetylase SIRT2

  2001cited by this paper
• Naphthyl ketones: a new class of Janus kinase 3 inhibitors.

  2000cited by this paper
• Structural motif of phosphate-binding site common to various protein superfamilies: all-against-all structural comparison of protein-mononucleotide complexes.

  1999cited by this paper

• Host–transposon interactions: conflict, cooperation, and cooption

  2019cites this paper
• Sirtuins in Alzheimer’s Disease: SIRT2-Related GenoPhenotypes and Implications for PharmacoEpiGenetics

  2019cites this paper
• Characterization of NOTCH signalling pathway in PTEN-deficient prostate tumorigenesis

  2018cites this paper
• Zinc and Copper Differentially Modulate Amyloid Precursor Protein Processing by γ-Secretase and Amyloid-β Peptide Production*

  2017cites this paper
• Inhibition of Poly(ADP-ribose) Polymerase-1 Enhances Gene Expression of Selected Sirtuins and APP Cleaving Enzymes in Amyloid Beta Cytotoxicity

  2017cites this paper
• The Alzheimer's Disease γ-Secretase Generates Higher 42:40 Ratios for β-Amyloid Than for p3 Peptides.

  2017cites this paper
• Inhibition of Notch pathway arrests PTEN-deficient advanced prostate cancer by triggering p27-driven cellular senescence

  2016cites this paper
• Regulated intramembrane proteolysis of the AXL receptor kinase generates an intracellular domain that localizes in the nucleus of cancer cells

  2016cites this paper
• The lipidome associated with the γ-secretase complex is required for its integrity and activity.

  2016cites this paper
• The FDA-approved natural product dihydroergocristine reduces the production of the Alzheimer’s disease amyloid-β peptides

  2015cites this paper
• Alzheimer's disease pathology is attenuated in a CD38‐deficient mouse model

  2015cites this paper
• The adipocyte differentiation protein APMAP is an endogenous suppressor of Aβ production in the brain

  2014cites this paper
• Mitochondrial signaling pathway in Alzheimer´s disease: disclosure of new therapeutic targets

  2014cites this paper
• Important functional role of residue x of the presenilin GxGD protease active site motif for APP substrate cleavage specificity and substrate selectivity of γ‐secretase

  2013influential citation
• Highly efficient production of the Alzheimer's γ‐Secretase integral membrane protease complex by a multi‐gene stable integration approach

  2013cites this paper
• Regulation and protection of mitochondrial physiology by sirtuins.

  2012cites this paper
• The Role of γ-Secretase Activating Protein (GSAP) and Imatinib in the Regulation of γ-Secretase Activity and Amyloid-β Generation*

  2012cites this paper
• Generation of monoclonal antibody fragments binding the native γ-secretase complex for use in structural studies.

  2012cites this paper
• Bioinorganic chemistry of Alzheimer's disease.

  2012cites this paper
• Drug-induced cardiac mitochondrial toxicity and protection: from doxorubicin to carvedilol.

  2011cites this paper
• Chemical Biology, Molecular Mechanism and Clinical Perspective of γ-Secretase Modulators in Alzheimer’s Disease

  2011cites this paper
• Mitochondria: the common upstream driver of amyloid-β and tau pathology in Alzheimer's disease.

  2011cites this paper